Developing countries that have large populations must be prepared in the face of the emergence of new diseases, therefore DCVMN prioritizes vaccine development, among others, of Pentavalent / Hexavalent Vaccines, Pneumococcal Conjugate, Rotavirus, Typhoid Conjugate, Human Papilloma, Measles / Rubella and Inactivated Polio Vaccines, he added.
The Management of Bio Farma is proud of the re-election of Mahendra Suhardono as the president of DCVMN for a second period, and the firm election of a candidate from the vaccine manufacturing representatives of a wide range of countries, such as Brazil, China, India, South Africa.
DCVMN Member Country Information: Argentina, Brazil, Cuba, Egypt, India, Indonesia, Iran, Mexico, People's Republic of China, Republic of Korea, Romania, South Africa, Thailand, Viet Nam, South Korea, Iran
DCVMN is a voluntary public health driven alliance of vaccine manufacturers from developing countries that aims to make a consistent supply of high quality vaccines that are accessible to protect people against known and emerging infectious diseases globally.
The newly-elected president of the DCVMN, Mahendra Suhardono of Bio Farma, expressed his optimism that the organization could be better and become stronger, especially under his leadership for the next two years.
According to Mahendra, Indonesia has already achieved a "sound, technological platform" in vaccine production and therefore looks forward to establishing cooperation in vaccine research and developments with other DCVMN member countries.
Member states of the DCVMN are Argentina, Bangladesh, Brazil, Cuba, Egypt, India, Indonesia, Iran, Mexico, Republic of China, Republic of Korea, South Africa, Thailand and Vietnam.
DCVMN works to strengthen vaccine manufacturers through the provision of information programs and professional training on technical improvements, research in vaccine production, encouraging technology transfer initiatives, and educating the public about the availability of safe and effective vaccines, from developing world manufacturers and related programs.
DCVMN was established in Bandung that year, he revealed, as WHO was concerned about the imbalanced playing field of vaccine production at the time when the developed world held dominance of vaccine production.
Rahman Roestan, corporate secretary of Bio Farma, has ealier said the Bali international vaccine-making meeting will be attented by more than 100 vaccine experts and high ranking health officials from DCVMN member states and other countries as well as UN bodies.
member countries are Argentina, Bangladesh, Brazil, Cuba, Egypt, India, Indonesia, Iran, Mexico, Republic of China, Republic of Korea, South Africa, Thailand and Vietnam.
In total, there are currently 37 vaccine-making organizations and company members in the 14 DCVMN